#hormone-naive — Wednesday, October 14, 2026 (1 items)
| 29 | ℹ |
Talazoparib plus enzalutamide in high-volume metastatic hormone-naive prostate cancer: a randomized phase 2 trial.
(nature.com)
|
Nature Medicine 2026-10-14 | #prostate cancer #clinical trial #parp inhibitor #metastatic #hormone-naive |